The inhibition of the binding of vascular endothelial growth factor (VEGF) to its receptor could suppress the development of cancer by restraining tumor angiogenesis, characterized by aberrant and undifferentiated vessels, and by accumulating T cell infiltration into the tumor, stimulating tumor immune responses, and enhancing T cell-mediated tumor cell killing [39]. This evidence concerns the gene VEGFA and neoplasm.